For this fireside chat, we welcome Dyadic, Inc., which trades on the NASDAQ under the ticker DYAI. Joining us from the company is Mark Emalfarb, Chief Executive Officer.

Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical and bio-industrial products for human and animal health and alternative proteins.

This Fireside Chat was recorded during the Lytham Partners Spring 2024 Investor Conference.